Frank Yocca, Chief Scientific Officer: BioXcel Therapeutics BTAIQ Sell · Filed 23/03/16

Trade details

Type: Insider sale
Amount: $19,394.65
Shares · price: 985 sh · $19.69 a share
Held after: 9,496 sh
Stock: BioXcel Therapeutics BTAIQ
Person: Frank YoccaChief Scientific Officer
Trade date: 23/03/15
Filed: 23/03/16
Days to filing: 1 days

Sold 9.4% of holdings

Share of holding sold: 9.4%

BioXcel Therapeutics trades, last 26 weeks

What else happened in BioXcel Therapeutics around then

Filed or reported within 30 days of the trade day · 23/02/13~23/04/14

Frank Yocca's recent trades

Frank YoccaChief Scientific Officer
Sell10b5-1 planBioXcel Therapeutics
Sell10b5-1 plan
BioXcel Therapeutics
BTAIQ
$7,461
6,845 sh
$7,461
Filed 05/22
Traded 05/20
Frank YoccaChief Scientific Officer
Planned sale10b5-1 planBioXcel Therapeutics
Planned sale10b5-1 plan
BioXcel Therapeutics
BTAIQ
$7,430
6,845 sh
$7,430
Filed 05/20
Traded 05/20
Frank YoccaChief Scientific Officer
Sell10b5-1 planBioXcel Therapeutics
Sell10b5-1 plan
BioXcel Therapeutics
BTAIQ
$79
225 sh
$79
Filed 24/12/17
Traded 24/12/16
Frank YoccaChief Scientific Officer
Sell10b5-1 planBioXcel Therapeutics
Sell10b5-1 plan
BioXcel Therapeutics
BTAIQ
$74
205 sh
$74
Filed 24/12/17
Traded 24/12/16
Frank YoccaChief Scientific Officer
Sell10b5-1 planBioXcel Therapeutics
Sell10b5-1 plan
BioXcel Therapeutics
BTAIQ
$3,946
7,175 sh
$3,946
Filed 24/10/03
Traded 24/10/03